Related Experiment Video
Updated: Feb 5, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Preventing Pediatric Respiratory Syncytial Virus Infection
Insights
Respiratory syncytial virus (RSV) infection poses a significant global health threat to infants. Current prevention focuses on high-risk infants, but new clinical research offers hope for broader infant protection against RSV.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Respiratory syncytial virus (RSV) is a leading cause of infant illness and death globally.
- Existing RSV prevention strategies, like monoclonal antibodies, target only the highest-risk infants.
- Development of safe and effective RSV vaccines remains a critical unmet medical need.
Purpose of the Study:
- To review promising RSV prevention strategies currently under investigation.
- To highlight progress in clinical research for RSV interventions.
- To discuss the potential for broader infant protection against RSV.
Main Methods:
- Review of current clinical trial data for novel RSV interventions.
- Analysis of emerging RSV vaccine and prophylaxis candidates.
- Synthesis of research findings on RSV prevention.
Main Results:
- Significant advancements in clinical research for RSV prevention are evident.
- Several promising approaches are advancing through clinical trials.
- The review synthesizes the latest progress in the field.
Conclusions:
- Despite challenges, substantial progress is being made in developing new RSV prevention methods.
- Future RSV prevention programs may offer broader protection beyond current high-risk groups.
- Ongoing clinical research is crucial for combating the global burden of infant RSV infection.
Abstract:
Respiratory syncytial virus (RSV) infection in infants is a major cause of morbidity and mortality worldwide. Despite intense research efforts, safe and effective vaccines have remained elusive. Risk factors for the development of severe disease are well known, and those infants at highest risk are identified to receive RSV prophylaxis in the form of anti-RSV monoclonal antibody. Still, many other infant groups remain at risk and could benefit from an effective RSV prevention program. An explosion of clinic research activity is bringing unprecedented progress. Several of the most promising approaches currently being evaluated in clinical trials are reviewed. [Pediatr Ann. 2018;47(9):e371-e376.].
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
What are Viruses?
Cancer Prevention
Some...
Anatomy of Respiratory System II: Lower Respiratory Tract
The Larynx
It is located between the pharynx and the trachea, acts as a passageway for air, and hosts several critical structures, such as the epiglottis, vocal cords, and glottis. The epiglottis acts as a gateway, guiding food to the...
The Respiratory System
Anatomy of Respiratory System I: Upper Respiratory Tract
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....

